切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Inward Rectifier Potassium (Kir) Channels - Ubiquitin-specific proteases - Vacuolar-type ATPase - Cathepsins

19件产品中的 1-10

页面
每页
清除全部
  1. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  2. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  3. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  4. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  5. Concanamycin A
    A8633 Concanamycin A
     1 Citation
    中文名: 卡那霉素A
    Target: Vacuolar-type ATPase
    Summary: V型(液泡)H +-ATP酶抑制剂
      soluble in DMSO
  6. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  7. Odanacatib (MK-0822)
    A2487 Odanacatib (MK-0822)
    中文名: 奥当卡替
    Target: Cathepsins
    Summary: 组织蛋白酶K抑制剂
      ≥17.7 mg/mL
      insoluble in H2O
  8. CA-074 Me
    A8239 CA-074 Me
     7 Citation
    Target: Cathepsins
    Summary: Cathepsin B抑制剂
      ≥19.88 mg/mL
      insoluble in H2O
  9. SID 26681509
    A4424 SID 26681509
    Target: Cathepsins
    Summary: 人组织蛋白酶L抑制剂
      <26.98 mg/mL
      <5.4 mg/mL
  10. MDL 28170
    A4412 MDL 28170
    Target: Cathepsins|Calpains
    Summary: Calpain和cathepsin B抑制剂
      ≥16.75 mg/mL
      insoluble in H2O

19件产品中的 1-10

页面
每页